top of page
Executive Spotlights

Bristol Myers Squibb buys Mirati for up to $5.8B

Lawrenceville, NJ, October 9, 2023 (Yahoo Finance) -- Bristol-Myers Squibb (BMY) has announced its acquisition of cancer drug manufacturer Mirati Therapeutics (MRTX) for a potential sum of $5.8 billion. This strategic move will expand Bristol-Myers Squibb's cancer drug portfolio.

Read full article here.

Recent Posts

See All


Life Science Headlines
bottom of page